ArticleOncogene2022

TRAF4 hyperactivates HER2 signaling and contributes to Trastuzumab resistance in HER2-positive breast cancer.

Yayun Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.